Impact of delay in surgery or time to surgery on kidney cancer outcomes

A recent study published in the Journal of Urology this month looked at the waiting times from diagnosis to surgery and the impact this had on outcomes for kidney cancer patients. The time from diagnosis of a kidney tumour to removal of the tumour during surgery can be very worrying for patients and clinicians due […]

read more

Surgical treatment of inferior vena cava tumour thrombi in kidney cancer

The formation of a cancerous blood clot, or thrombus, in one of the main veins that transport blood from the body to the heart, the inferior vena cava, can be a complication in patients with renal cell carcinoma (RCC), occurring in 5-15% of cases. A recent study investigated the surgical treatment of kidney cancer patients […]

read more

Clinical impact of COVID-19 on people with cancer

A recent publication in The Lancet looked at the effect of COVID-19 on the treatment of people with cancer. Data from cancer patients living in the USA, Canada and Spain who were infected with coronavirus were analysed. Nine hundred and twenty eight (928) people with an active or previous cancer and confirmed severe acute respiratory […]

read more

IKCS 2019: Management of small renal masses

In this video interview, Dr Eric Singer from Rutgers Cancer Institute of New Jersey, USA discusses the management of small renal masses at the International Kidney Cancer Symposium (IKCS) in Miami earlier this month. Watch the video interview on Oncology Tube here

read more

ASCO 2019: Immunotherapy before surgery for treating metastatic kidney cancer

The results of this open-label pilot study were presented at the American Society of Clinical Oncology (ASCO) 2019 annual meeting in Chicago earlier this week. The study investigated the use of neoadjuvant (before surgery) immunotherapy in patients with metastatic renal cell carcinoma (RCC). One hundred and five patients with metastatic RCC were randomised to receive […]

read more

Kidney cancer experts talk about the latest advances in treatments

The following interviews with kidney cancer experts discuss the latest advances in the treatment of renal cell carcinoma (RCC) and renal masses: No OS signal in axitinib + avelumab combination therapy – Dr Toni Choueiri, Dana Faber Cancer Institute, Boston, USA Treating renal masses with minimal invasive ablative technique – Dr Alessandro Volpe, Maggiore Della […]

read more

Microwave ablation for early stage renal masses

Researchers from the Mayo Clinic in Rochester, USA, have published a retrospective review of the use of microwave ablation in the American Journal of Roentgenology (AJR). The review describes percutaneous (through the skin) microwave ablation as a promising treatment for patients with early stage (T1) renal tumours. However, more research into the selection of patients due to […]

read more

ASCO GU 2019: Questions and lessons moving forward from CARMENA: A medical oncologist’s perspective

The following paper was presented at the American Society for Clinical Oncology (ASCO) genitourinary (GU) conference in San Francisco in February 2019. Cytoreductive nephrectomy (CN) is defined as the surgical removal of the primary renal cell carcinoma (RCC) tumour before starting systemic therapy. The following paper from medical oncologist Dr Lauren Harshman, Dana-Farber Cancer Institute, Boston, USA, suggests that this is an […]

read more

ASCO GU 2019: Questions and lessons moving forward from CARMENA: A surgeon’s perspective

The following paper was presented at the American Society for Clinical Oncology (ASCO) genitourinary (GU) conference in San Francisco in February 2019. Cytoreductive nephrectomy (CN) is defined as the surgical removal of the primary renal cell carcinoma (RCC) tumour before starting systemic therapy. The following paper from surgeon Dr Paul Russo, Memorial Sloan Kettering Cancer […]

read more
Showing 1 to 10 of 22 results
  TOP